Key points are not available for this paper at this time.
Mice pretreated with complete Freund's adjuvant had an enhanced resistance to autochthonous and transplanted tumors. Delayed time to death and/or increased survival was noted in CFA pretreated mice grafted intraperitoneally with Sarcoma 180, leukemia L1210, or Friend leukemia spleen cells. In addition, CFA pretreatment caused a statistically significant delay in spontaneous mammary tumor development in C3H/HeJ mice and spontaneous leukemia in AKR mice. We propose that host resistance to intracellular infectious agents and neoplasia is related in a fundamental way and the activated macrophage is a common effector arm for expression of this resistance. It is also suggested that a nonimmunologic growth control mechanism such as we have described offers a rapid acting homeostatic process for destruction of cells with abnormal growth properties in vivo.
Hibbs et al. (Wed,) studied this question.